Navigation Links
Pivotal Phase 3 Data from Boehringer Ingelheim Hepatitis C Portfolio to be Presented at 64th Annual AASLD Meeting
Date:10/1/2013

ster Hall Interferon-Free Treatment with

Faldaprevir, Deleobuvir (BI 207127)

and Ribavirin in SOUND-C3: 95% SVR12

in HCV-GT1b

J.F. Dufour

ID# 1102
Session: HCV Therapeutics: New
Agents
Date: Sun, Nov. 3
Time: 8:00 AM – 5:30 PM ET
Location: Poster Hall STARTVerso 4 Phase III trial of

faldaprevir plus peg interferon alfa-2a

and ribavirin (PR) in patients with HIV

and HCV genotype 1 coinfection:

end of treatment response

J. Rockstroh

ID# 1099
Session: HCV Therapeutics: New
Agents
Date: Sun, Nov. 3
Time: 8:00 AM – 5:30 PM ET
Location: Poster Hall Pharmacokinetic interactions of

Faldaprevir and Deleobuvir (BI 207127)

and their individual and combined effect on

selected cytochrome P450 (CYP) probe

substrates in genotype 1 hepatitis C

infected patients

C. Cooper

ID# 1083
Session: HCV Therapeutics: New
Agents
Date: Sun, Nov. 3
Time: 8:00 AM – 5:30 PM ET
Location: Poster Hall About Boehringer Ingelheim in Hepatitis C Virus (HCV)
In partnership with the scientific community, our clinical trial program is rigorously designed to find answers to the challenges that HCV patients face, including those who are the most difficult to treat. Our pivotal HCV clinical trials for faldaprevir and deleobuvir are comprised of two multi-trial programs, STARTVerso and HCVerso®.

Faldaprevir, also known as BI 201335, is an investigational, oral protease inhibitor that is specifically designed to target viral replication in the liver. Boehringer Ingelheim is developing faldaprevir as a core component of both interferon-based and interferon-free hepatitis C treatment regimens. STARTVerso is a multi-study Phase 3 trial program that evaluates faldaprevir combined with PegIFN/RBV. The four trials that make up this program study
'/>"/>

SOURCE Boehringer Ingelheim
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. EntreMed Initiates Crossover Bioavailability And Food Effect Study Of ENMD-2076 Dosage Form To Be Used For Pivotal/Registration Clinical Trials
2. Shield Therapeutics Completes Recruitment to Pivotal Phase 3 Programme for Treatment of Iron Deficiency
3. CSL Behring Doses First Patient in Part 3 of Global Phase I/III Pivotal Study of rVIII-SingleChain (Recombinant Single-Chain Factor VIII) for Treatment of Hemophilia A
4. Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain
5. Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
6. Relievant Medsystems Achieves Completion of Interim Safety Data Analysis of Intracept in SMART Pivotal Study and Expands Senior Leadership Team
7. Boehringer Ingelheim to Announce Pivotal Phase 3 Hepatitis C Data at the International Liver Congress
8. Venaxis Advances Pivotal U.S. Study and Accelerates European Market Development for APPY1 Blood-based Appendicitis Test
9. AcelRx Top-line Data Show Primary Endpoint Achieved in Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Post-Operative Pain in Major Open Abdominal Surgery Patients
10. First U.S. Patients Treated in PneumRx RENEW Pivotal Study for Treatment of Severe Emphysema
11. ADVENTRX Initiates Pivotal Phase 3 Study of ANX-188
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... Sept. 4, 2015  Dohmen Company CEO Cynthia ... Metropolitan Milwaukee Association of Commerce,s annual ,Future 50, Awards ... Pfister Hotel. The ,Future 50, Awards highlights the achievements ... young firms headquartered in the seven-county Milwaukee ... Milwaukee home for more than ...
(Date:9/4/2015)... Texas , Sept. 4, 2015  Luminex Corporation ... present at the Morgan Stanley Global Healthcare Conference to ... Grand Hyatt Hotel in New York City ... at 11:40 a.m. Eastern time on Friday, September 18, ... accessed at Luminex Corporation,s website at http://www.luminexcorp.com . ...
(Date:9/4/2015)... 4, 2015 According to a ... Plateletpheresis, Erythrocytapheresis, Leukapheresis, and Photopheresis) by Procedure (Therapeutic Apheresis, ... - Global Forecast to 2020", published by MarketsandMarkets, the ... Billion by 2020, growing at a CAGR of 11.2% ... Browse 139 Tables and 45 F ...
Breaking Medicine Technology:Dohmen CEO Cynthia LaConte to Keynote MMAC 'Future 50' Awards Luncheon 2Luminex Corporation To Present At The Morgan Stanley Global Healthcare Conference 2Apheresis Market Worth 2.5 Billion USD by 2020 2Apheresis Market Worth 2.5 Billion USD by 2020 3Apheresis Market Worth 2.5 Billion USD by 2020 4Apheresis Market Worth 2.5 Billion USD by 2020 5
... PRINCETON, N.J., Aug. 24, 2011 Pharmasset, Inc. (Nasdaq: ... U.S. Food and Drug Administration (FDA) for PSI-938 for the ... an oral guanosine nucleotide analog polymerase inhibitor of HCV. ... NUCLEAR study demonstrating that PSI-938 has potent antiviral activity and ...
... YORK, Aug. 23, 2011 Wendy ... Cabraser Heimann & Bernstein, LLP announced that Tiffany Littles, 33, ... Healthcare Pharmaceuticals, Inc., for severe and lasting injuries caused by ... is a dangerous prescription drug sold without adequate warnings about ...
Cached Medicine Technology:PSI-938 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection 2PSI-938 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection 3Florida Woman Charges Life-Threatening Blood Clot Caused by Yaz Birth Control Drug According to Lieff Cabraser Heimann & Bernstein, LLP 2
(Date:9/4/2015)... ... September 04, 2015 , ... Scalability ... of the Year” awards at this year’s Microsoft Worldwide Partner Conference that was ... of the Year” Award Winner for Data Platform services, the 2015 HP and ...
(Date:9/4/2015)... , ... September 04, 2015 , ... Many consumers are looking for a quick and ... their solution. , The patent-pending K Med Cups provide a quick and simple way to ... relieve a cold, flu or cough. As a result, they enhance comfort and health. The ...
(Date:9/4/2015)... ... September 04, 2015 , ... ECC ... first neighborhood created specifically for adults with intellectual, developmental and acquired disabilities. The ... and feature 30 cottage or “pocket” homes. In this community, adults will live ...
(Date:9/4/2015)... NC (PRWEB) , ... September 04, 2015 , ... ... filtration products, has a Labor Day offer that cannot be passed up. ... stock up on necessary air and water filtration product replacements. Take advantage of ...
(Date:9/3/2015)... ... September 03, 2015 , ... Allied Anesthesia is proud to announce a ... norm not the exception. , St. Jude was recently named one of the nation’s ... making it one of only 10 hospitals in the state to earn the distinction. ...
Breaking Medicine News(10 mins):Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 4Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4Health News:FiltersFast.com Wows with a Long Labor Day Weekend Shipping Offer 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 3
... SATURDAY, Jan. 16 (HealthDay News) -- Allergy vaccinations reduce ... one-third and drug prescription costs by 16 percent, according ... the medical claims for 2,770 children with hay fever ... of 11,000 children with allergic rhinitis who didn,t receive ...
... ... the cost of their Diabetes Panel to $89 for the month of January. Symptoms of ... your hands or feet. , ... TX (Vocus) January 16, 2010 -- ANY LAB TEST NOW North Dallas locations have lowered the ...
... , OAKLAND, Calif. , Jan. 15 ... to four national disaster relief organizations to provide aid ... .  The nonprofit health care organization has wired the funding ... International, and is providing expertise and support to U.S. disaster ...
... , MARINA DEL RAY, Calif., Jan. 15 Dr. ... to announce he is sending much needed assistance to the Haitian earthquake ... doctors and staff are leaving Jan 25 & 26. The ... be able to treat hundreds of patients a day at their clinic. ...
... OAKLAND, Calif. , Jan. 15 Nearly 7,500 registered nurses ...  believed to be the largest outpouring of RN volunteers in U.S. history, ... the clock to find locations for the nurses to deploy on the ... through the NNU program as well. , View the attached ...
... , SOUTHFIELD, Mich. , Jan. 15 As ... relief organization, Life for Relief and Development (Life) in partnership with ... a prominent humanitarian relief organization in the United Arab Emirates ... the victims of the recent earthquake in Haiti . , ...
Cached Medicine News:Health News:Shots Relieve Children's Hay Fever, Cut Expenses 2Health News:ANY LAB TEST NOW North Dallas Lowers Diabetes Testing to $89 2Health News:Kaiser Permanente Donates $500,000 for Relief Efforts Following Earthquake in Haiti 2Health News:Kaiser Permanente Donates $500,000 for Relief Efforts Following Earthquake in Haiti 3Health News:Heritage Provider Network, Dr. Richard Merkin, Comes to the Aid of Haitian Earthquake Victims 2Health News:Nearly 7,500 RNs Ready to Deploy to Haiti 2Health News:Life for Relief & Dubai Charity to Send $1.25 Million in Emergency Relief for Haiti Earthquake Victims 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: